"IARC group 2A Carcinogens" reported in cigarette mainstream smoke.
about
Lung cancer: epidemiology, etiology, and preventionMolecular mechanism of acrylamide neurotoxicity: lessons learned from organic chemistryHazardous compounds in tobacco smokeThe acrylamide content of smokeless tobacco productsExposure of the U.S. population to acrylamide in the National Health and Nutrition Examination Survey 2003-2004Geographical Variation and Factors Associated with Non-Small Cell Lung Cancer in Manitoba.The composition of cigarette smoke: a retrospective, with emphasis on polycyclic components.Cigarette smoking during early pregnancy reduces the number of embryonic germ and somatic cells.Safety assessment of mainstream smoke of herbal cigarette.Research opportunities related to establishing standards for tobacco products under the Family Smoking Prevention and Tobacco Control ActCigarette side-stream smoke lung and bladder carcinogenesis: inducing mutagenic acrolein-DNA adducts, inhibiting DNA repair and enhancing anchorage-independent-growth cell transformation.The role of skin painting in predicting lung cancer.Chromosomal mosaicism in mouse two-cell embryos after paternal exposure to acrylamide.Tobacco smoke-related health effects induced by 1,3-butadiene and strategies for risk reduction.Negative association between acrylamide exposure and body composition in adults: NHANES, 2003-2004.Acrylamide analysis in food by liquid chromatographic and gas chromatographic methods.Functional genomics annotation of a statistical epistasis network associated with bladder cancer susceptibility.Diverse action of acrylamide on cytochrome P450 and glutathione S-transferase isozyme activities, mRNA levels and protein levels in human hepatocarcinoma cells.Urinary mercapturic acids and a hemoglobin adduct for the dosimetry of acrylamide exposure in smokers and nonsmokers.The number of oogonia and somatic cells in the human female embryo and fetus in relation to whether or not exposed to maternal cigarette smoking.Breast cancer and exposure to tobacco smoke during potential windows of susceptibility.Isotope Dilution nanoLC/ESI+-HRMS3 Quantitation of Urinary N7-(1-Hydroxy-3-buten-2-yl) Guanine Adducts in Humans and Their Use as Biomarkers of Exposure to 1,3-Butadiene.Differences in cadmium transfer from tobacco to cigarette smoke, compared to arsenic or lead.Systemic immunosuppression following a single pharyngeal aspiration of 1,2:5,6-dibenzanthracene in female B6C3F1 mice.Chemical analysis of cigarette smoke particulate generated in the MSB-01 in vitro whole smoke exposure system.Challenges in estimating the validity of dietary acrylamide measurements.Biological monitoring for occupational acrylamide exposure from acrylamide production workers.Excretion of 2,3-dihydroxy-propionamide (OH-PA), the hydrolysis product of glycidamide, in human urine after single oral dose of deuterium-labeled acrylamide.Evaluation of time dependence and interindividual differences in benzo[a]pyrene-mediated CYP1A1 induction and genotoxicity in porcine urinary bladder cell cultures.Scientific Opinion on acrylamide in foodThe impact of tobacco additives on cigarette smoke toxicity: a critical appraisal of tobacco industry studies.Dietary determinants for Hb-acrylamide and Hb-glycidamide adducts in Danish non-smoking women.Acrylamide-induced disturbance of the redox balance in the chick embryonic brain.Dietary acrylamide intake of adults in the European Prospective Investigation into Cancer and Nutrition differs greatly according to geographical region
P2860
Q24630167-460BCB0E-CCD9-4A20-8CE1-5904A2FFA878Q26999354-9DE1D8AB-CDCD-4AEF-A9C4-13D85FF19576Q28237162-3772B18E-C61F-4EC2-96BF-1401DA0780A0Q28390937-E163A26D-536A-4D23-860A-4425E5820CFCQ33702726-08F58368-67B2-4F17-9F5A-B1289EADE71EQ33877570-9F928CE0-3048-4C46-A1D3-C7FD66FEC561Q34158322-DBC1B0DF-0F68-47BA-9F7F-0001A848FC4EQ34623194-12F7BEC6-63A5-4AA7-92B4-FC90AD9F4710Q35397445-1C7D7C1E-3FB1-4918-924D-F3CC602BAFA8Q35624461-697B30C4-7762-4159-A4A9-B89E94938267Q36545118-A8AA4D26-2922-4E56-9DF5-D34CBFA45DA0Q36895451-3597C3F9-93CA-474F-BE8D-43E9F2E4C5FDQ37327116-06FE3F65-C0A6-4792-B021-877ED5F0F5D6Q37380761-09A2CC1F-72CD-4049-B3E7-E7B3BEF97A38Q37737768-507F7B47-3EA8-4885-96C3-945C805F2C2EQ38267674-34995BCF-43F6-40CB-BCC8-91E7BE0A4C31Q38799961-966F4325-1B40-4141-9FA6-6A46F8DB05FFQ39385006-4FE2B3D8-9CE9-4386-8825-6C6C3CA922C6Q39758958-F726D1DA-12FC-4FCB-9940-4A9377FB94B5Q39968219-2B072921-B2BD-462E-9C68-E65901152396Q40195564-DAF060B8-4EAC-4C51-9449-E6905592BD23Q41047455-F3382399-951C-43E9-AFC6-33CCCC7BBC52Q41680883-04F37837-8614-4A19-9DE8-97ED67D06D85Q43051404-0C3E692A-B13B-4390-9328-C2EEB414AB06Q43273058-4047EFE1-C70C-428A-A001-C96DBF2E3041Q43441117-FB73BC87-DE51-4EC2-A697-1EE47D5FFCB1Q44446052-AF96CDE2-1554-4D76-9287-58C8BD02A966Q45578881-420AB76E-87B6-44FF-BA14-FE0F3A106CF3Q46527345-2F4B2F80-2476-4B13-BFB3-385CE1937AAEQ47157011-B3661D05-441B-4C17-AEC9-4FB22EA7A27DQ49719395-4D133A56-D55E-4397-A886-41BCCC9F1E7FQ50553080-E385078F-78F2-44F0-A173-9B48A9B0FE11Q52095678-49A2EAAC-545F-4BA4-95B3-687D8185FBE1Q57271316-F74D4BA0-5012-4F98-8908-35E835325E0E
P2860
"IARC group 2A Carcinogens" reported in cigarette mainstream smoke.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
"IARC group 2A Carcinogens" reported in cigarette mainstream smoke.
@ast
"IARC group 2A Carcinogens" reported in cigarette mainstream smoke.
@en
type
label
"IARC group 2A Carcinogens" reported in cigarette mainstream smoke.
@ast
"IARC group 2A Carcinogens" reported in cigarette mainstream smoke.
@en
prefLabel
"IARC group 2A Carcinogens" reported in cigarette mainstream smoke.
@ast
"IARC group 2A Carcinogens" reported in cigarette mainstream smoke.
@en
P2093
P1476
"IARC group 2A Carcinogens" reported in cigarette mainstream smoke.
@en
P2093
Doolittle DJ
Perfetti TA
P304
P356
10.1016/S0278-6915(99)00156-8
P577
2000-04-01T00:00:00Z